On June 17, 2020, Michael Barnes, JD presented alongside Wade Delk, Government Affairs Director of the American Society for Pain Management Nursing (ASPMN), for the Providers Clinical Support System (PCSS) 2020 Pain Care Legislation and Public Policy Webinar. Mr. Barnes and Mr. Delk provided an update on state and federal legislative and regulatory actions and […]
On February 26, 2020, DEA issued a proposed rule titled Registration Requirements for Narcotic Treatment Programs with Mobile Components. The proposed rule would waive the requirement of a separate registration for opioid treatment programs (OTPs) that utilize a mobile component. The Controlled Substances Act (CSA) generally requires, with certain exceptions, all persons who dispense controlled […]
Michael Barnes, JD recently made an appearance on Fox Business Live, where he discussed conflicting messages about the impact of the U.S. drug abuse crisis on corporate profits. Mr. Barnes then analyzed drug pricing bills in Congress and how they could affect Americans’ access to new medicines for conditions like Alzheimer’s and cancer. The original […]
Michael C. Barnes, JD spoke today at the Choctaw Nation Health Services Authority Conference in Durant, Oklahoma. Mr. Barnes’ presentation, “Compassion and Common Sense: Emergency Responses to Substance Abuse and Mental Illness,” provided information on the nation’s overdose crisis and delved into some of the major initiatives that have been undertaken at the federal and […]
On September 19, 2019, Michael C. Barnes, JD presented alongside Wade Delk, Government Affairs Director of the American Society for Pain Management Nursing (ASPMN), and Marsha Stanton, Ph.D., R.N., former president of ASPMN, at ASPMN’s 29th annual conference in Portland, Oregon. Their presentation, titled “Trends in Federal Law, Regulation, and Enforcement, and Their Impacts on […]